Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Melea A. Ward, PharmD, MS
Clinical Pharmacist,
Humana, Inc, Louisville, KY,
at the time this work was completed
Clinical Pharmacist, Humana, Inc, Louisville, KY, at the time this work was completed
Authored Items
Is Response-Guided Therapy Being Applied in the Clinical Setting? The Hepatitis C Example
Jennifer B Harris, PharmD
,
Jack E. Fincham, PhD, RPh
,
Phil Schwab, PhD
,
Melea A. Ward, PharmD, MS
February 2015 Vol 8, No 1
in
Original Research
Lessons from the Leucovorin Shortages Between 2009 and 2012 in a Medicare Advantage Population: Where Do We Go from Here?
Mary S. Hayes, PharmD
,
Joseph P. Fuhr, Jr, PhD
,
S. Lane Slabaugh, PharmD, MBA
,
Melea A. Ward, PharmD, MS
,
Yihua Xu, PhD
August 2014 Vol 7, No 5
in
Business
Last modified: February 24, 2015